Glycomet Trio 1 Tablet SR
Glycomet Trio 1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹97
that's 75% off!
About This Medicine
Product description & overview
Glycomet Trio 1 Tablet SR: A Comprehensive Diabetes Management Solution
Glycomet Trio 1 Tablet SR is a once-daily combination medication for adults with Type 2 diabetes. It provides comprehensive control over blood sugar levels by acting on three key mechanisms:
* Glimepiride: This sulfonylurea drug enhances insulin secretion from the pancreas, helping lower blood glucose levels.
* Metformin: A biguanide that works to reduce liver glucose production and improve insulin sensitivity in cells.
* Voglibose: This alpha-glucosidase inhibitor slows down the absorption of carbohydrates into the bloodstream, further contributing to improved glycemic control.
Glycomet Trio 1's unique combination provides a multifaceted approach to managing Type 2 diabetes symptoms. It offers convenience as well as efficient blood sugar regulation.
Consult your healthcare professional before use to confirm suitability and follow their dosage instructions.
Please note: This product is for informational purposes only and does not constitute medical advice. Always seek guidance from qualified medical professionals regarding your health concerns.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glycomet Trio 1 Tablet SR.
High Risk
Pregnancy
Glycomet Trio 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glycomet Trio 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glycomet Trio 1 Tablet SR may be needed. Please consult your doctor. Glycomet Trio 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glycomet Trio 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glycomet Trio 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glycomet Trio 1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glycomet Trio 1 Tablet SR
Products matching your search
Glyphmet M2 Tablet SR
Glyphmet M2 Tablet SR
Fluticaphar Nasal Spray
Fluticaphar Nasal Spray
Enmox KT Eye Drop BAK Free
Enmox KT Eye Drop BAK Free
Gzor M Forte 1mg/1000mg Tablet
Gzor M Forte 1mg/1000mg Tablet
Efigraine 10mg Tablet
Efigraine 10mg Tablet
Flezonac TH 100mg/8mg Tablet
Flezonac TH 100mg/8mg Tablet
Glycostar M Forte 2mg/1000mg Tablet SR
Glycostar M Forte 2mg/1000mg Tablet SR
Gudgesic SP 100mg/325mg/15mg Tablet